major adverse cardiovascular event
Showing 1 - 25 of >10,000
Characterization of Arrhythmia-induced Cardiomyopathy
Recruiting
- Cardiomyopathy
- Arrhythmia-induced Cardiomyopathy (AiCM)
- Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)
- +3 more
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Cardiology
Jan 2, 2023
DOAC in Chinese Patients With Atrial Fibrillation
Recruiting
- Atrial Fibrillation
- +6 more
- Blood Tests
-
Hong Kong, Hong KongChinese University of Hong Kong
Oct 11, 2022
Endovascular Thrombectomy Trials Into Real-world Practice in
Recruiting
- Ischemic Stroke
- +5 more
- Thrombus analyses
- Imaging assessment
-
Linyi, Shandong, China
- +2 more
Nov 23, 2022
Impact of COVID-19 Vaccines on Cerebrovascular Health
Recruiting
- Stroke
- +9 more
- Laboratory tests and Montreal Cognitive Assessment
-
Hong Kong, Hong KongChinese University of Hong Kong
Mar 7, 2022
Major Adverse Cardiovascular Events Using Remote Monitoring
Completed
- Ischemic Heart Disease
- Laboratory Biomarker Analysis
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 19, 2020
Long Term Cardiovascular Disease Event Risk for Patients
Not yet recruiting
- Cardiovascular Diseases
- Risk Reduction Behavior
- Healthy lifestyle behaviors around the time of surgery
- (no location specified)
Feb 8, 2023
Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)
Not yet recruiting
- Primary Prevention of Atherosclerotic Cardiovascular Disease
- Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
- Placebo in 1.5ml
- (no location specified)
Feb 13, 2023
Inclisiran on Major Adverse Cardiovascular Events in French
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Inclisiran sodium
- +3 more
- (no location specified)
Jul 26, 2023
Suspicion of Cardiovascular Events on Immunecheckpoint
Recruiting
- Cancer
- +3 more
- No intervention for research purposes only
-
Paris, FranceIntitut Mutualiste Montsouris
Mar 23, 2023
B-cell Malignancies Undergoing Treatment With Bruton Tyrosine
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 22, 2023
Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)
Not yet recruiting
- Arteriosclerosis
- Hypercholesterolaemia
- MK-0616
- Placebo
- (no location specified)
Aug 17, 2023
Diabetes, Type 2, Major Adverse Cardiac Events Trial in Hangzhou (CGM)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Major Adverse Cardiac Events
- CGM
-
Hangzhou, Chinathe Second Affiliated Hospital Zhejiang University Schoolof Medi
Sep 23, 2023
Anticoagulant Drug Intervention on Postoperative MALE and MACE
Recruiting
- Anticoagulant Drugs
- +2 more
- anticoagulant or antiplatelet drugs
-
Hangzhou, None Selected, ChinaFirst Affiliated Hospital of Zhejiang University
May 8, 2023
Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)
Not yet recruiting
- Obesity
- Naltrexone-Bupropion (NB) Combination
- Placebo
- (no location specified)
Oct 18, 2023
Cardiovascular Diseases, Lifestyle Risk Reduction Trial in Little Rock (lifestyle modification)
Completed
- Cardiovascular Diseases
- Lifestyle Risk Reduction
- lifestyle modification
-
Little Rock, ArkansasArkansas Heart Hospital-Clinic
Jan 23, 2023
Major Adverse Cardiovascular Events for Naldemedine and Other
Recruiting
- Opioid-induced Constipation
- Naldemedine
- +2 more
-
Wilmington, DelawareResearch Site
Feb 28, 2022
Major Adverse Cardiovascular Events in Coronary Artery Disease
Completed
- Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
-
Jinan, Shandong, ChinaYuguo Chen
Sep 20, 2022
Cardiovascular Primary Prevention Strategy Trial in Murray (Coronary Artery Calcium Screening and Statin Treatment, Standard
Recruiting
- Cardiovascular Primary Prevention Strategy
- Coronary Artery Calcium Screening and Statin Treatment
- Standard Treatment
-
Murray, UtahIntermountain Medical Center and Intermountain Clinics
Aug 8, 2022
Novel Cardiovascular Biomarkers in Patients With Kidney Disease
Not yet recruiting
- Haemodialysis Complication
- Major Adverse Cardiac Events
- Cardiac Biomarkers
- +2 more
- (no location specified)
Sep 14, 2023
Cardiovascular Diseases Trial in Peking (cardiovascular magnetic resonance (CMR))
Completed
- Cardiovascular Diseases
- cardiovascular magnetic resonance (CMR)
-
Peking, Beijing, ChinaChinese PLA General Hospital
Apr 3, 2022
![](/image/sponsor/university_of_campania_"luigi_vanvitelli")
GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Myocardial Infarction
- PCI
-
Naples, ItalyCelestino Sardu
Aug 31, 2023
Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)
Not yet recruiting
- Coronary Artery Disease Progression
- Intensive lipid-lowering control
- Moderate-intensity lipid-lowering control
- (no location specified)
Jul 13, 2022
Cancer, Immune-related Adverse Event, Cardiac Abnormalities, Variable Trial in Belgium (Cardiology consultation, Chest Computed
Recruiting
- Cancer
- +6 more
- Cardiology consultation
- +4 more
-
Deinze, East-Flanders, Belgium
- +3 more
Jan 26, 2023
Obstructive Hypertrophic Cardiomyopathy
Completed
- Microvascular Dysfunction
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital, China National Center for Cardiovascular Disease
Jan 11, 2023